Cargando…

Aggressive lymphoma 2016: revision of the WHO classification

Aggressive lymphomas are a heterogeneous group of malignancies reflecting clinical, biological and pathological diversity. Diffuse large B‑cell lymphoma is the most common histological subtype and therefore will constitute the key aspect in this article. This lymphoma affects patients of all age gro...

Descripción completa

Detalles Bibliográficos
Autor principal:	Beham-Schmid, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2017
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725508/ https://www.ncbi.nlm.nih.gov/pubmed/29250206 http://dx.doi.org/10.1007/s12254-017-0367-8

Ejemplares similares

Primary Cutaneous Aggressive Epidermotropic Cytotoxic T-cell Lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
por: Guitart, Joan, et al.
Publicado: (2017)

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
por: KOMORI, Takashi
Publicado: (2017)

Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification
por: Kriachok, Iryna, et al.
Publicado: (2022)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas
por: Balague Ponz, Olga, et al.
Publicado: (2009)

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
por: Inamura, Kentaro
Publicado: (2018)

Molecular classification of aggressive B-cell lymphoma
por: Bojarczuk, Kamil, et al.
Publicado: (2019)

Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival
por: Fechter, Karoline, et al.
Publicado: (2018)

The new WHO classification for essential thrombocythemia calls for revision of available evidences
por: Barbui, Tiziano, et al.
Publicado: (2020)

Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases
por: KHALLAAYOUNE, Mehdi, et al.
Publicado: (2020)

Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification
por: Inamura, Kentaro
Publicado: (2017)

Aggressive Inverted Papilloma with Intracranial Invasion and Short Malignization Time
por: Tomazic, Peter Valentin, et al.
Publicado: (2011)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
por: Hackshaw, A, et al.
Publicado: (2004)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
por: Narvaez, Federico, et al.
Publicado: (2011)

Nuances in the Management of Aggressive Lymphomas
por: Hamlin, Paul A., et al.
Publicado: (2017)

Molecular Profiling of Aggressive Lymphomas
por: Rossi, Maura, et al.
Publicado: (2012)

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
por: Barbui, Tiziano, et al.
Publicado: (2018)

Case Report: Epstein-Barr-Virus negative diffuse large B-cell lymphoma detected in a peri-prosthetic membrane
por: Sunitsch, Sandra, et al.
Publicado: (2016)

Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data
por: Kurz, Katrin S., et al.
Publicado: (2023)

Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification
por: Jung, Jin, et al.
Publicado: (2019)

Dual targeting of PI3K and BCL‐2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2022)

Response to Harrison et al. ‘Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'
por: Gisslinger, H, et al.
Publicado: (2017)

High and highly bonded: Fused football fans who use cocaine are most likely to be aggressive toward rivals
por: Newson, Martha
Publicado: (2021)

The revised WHO dengue case classification: does the system need to be modified?
por: Hadinegoro, Sri Rezeki S
Publicado: (2012)

Operative R0 resection of diffuse large B-cell lymphoma of the pelvis: a case report
por: Wienerroither, Valerie, et al.
Publicado: (2018)

Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts
por: Kurz, Katrin S., et al.
Publicado: (2023)

The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock
por: West, A C, et al.
Publicado: (2016)

Criteria of “persistent vomiting” in the WHO 2009 warning signs for dengue case classification
por: Vuong, Nguyen Lam, et al.
Publicado: (2016)

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas
por: Paul, Yashna, et al.
Publicado: (2017)

ASH Meeting 2016: developments in hemostaseology
por: Feistritzer, Clemens, et al.
Publicado: (2017)

Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma
por: Morgan, Elizabeth A., et al.
Publicado: (2012)

Immunohistochemistry for c‐myc and bcl‐2 overexpression improves risk stratification in primary central nervous system lymphoma
por: Hatzl, Stefan, et al.
Publicado: (2020)

Novel Therapies for Aggressive B-Cell Lymphoma
por: Foon, Kenneth A., et al.
Publicado: (2012)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition
por: Ota, Yasunori, et al.
Publicado: (2014)

A Revised Phylogenetic Classification for Viola (Violaceae)
por: Marcussen, Thomas, et al.
Publicado: (2022)

ASCO 2016 – update colorectal liver metastases
por: Kaczirek, Klaus
Publicado: (2017)

S4-KL-1 UPDATE OF WHO2016 CLASSIFICATION OF ADULT DIFFUSE GLIOMAS
por: Komori, Takashi
Publicado: (2019)

Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification
por: Yu, Juan, et al.
Publicado: (2020)

Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
por: SASAKI, Hikaru, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dvalie9lt9ohvb5r613jaa55vq